Key result
Sildenafil and Ba2+ synergistically inhibit IK1 by ~46% and prolong action potential duration.
Why the study?
Atrial or ventricular fibrillation may rarely occur during sildenafil therapy, but the effect of sildenafil on the inward rectifier potassium current (IK1) had not been studied.
The synergistic inhibition of IK1 by low concentrations of sildenafil and Ba2+ prolongs action potential duration, potentially explaining the rare occurrence of arrhythmias in patients treated with sildenafil.
Answers are grounded in this paper and cite their sources.
May link sildenafil to APD prolongation via IK1 in animals; hypothesis-generating, needs human validation before clinical relevance.
Sildenafil (Viagra) is a vasodilator mainly used in the treatment of erectile dysfunction. Atrial or ventricular fibrillation may rarely occur as a side effect during sildenafil therapy. Although changes in inward rectifier potassium currents including I K1 are known to contribute to the pathogenesis of fibrillation, the effect of sildenafil on I K1 has not been studied. In experiments, Ba 2+ is used as a specific inhibitor of I K1 at high concentrations (usually 100 µM). Being an environmental contaminant, it is also present in the human body; Ba 2+ plasmatic concentrations up to 1.5 µM are usually reported in the general population. This study was primarily aimed to investigate changes of I K1 induced by sildenafil in a wide range of concentrations (0.1–100 µM). Additionally, the effect of combination of sildenafil and Ba 2+ at selected clinically-relevant concentrations was tested, at 0.1 µM both on I K1 and on the action potential duration (APD). Experiments were performed by the whole-cell patch-clamp technique on enzymatically isolated rat ventricular cardiomyocytes, mostly at 23°C with the exception of APD measurements which were performed at 37°C as well. Sildenafil caused a significant, reversible, and concentration-dependent inhibition of I K1 that did not differ at −50 and −110 mV. Simultaneous application of sildenafil and Ba 2+ at 0.1 µM revealed a massive inhibition of both inward and outward components of I K1 (this synergy was missing at other tested combinations). The combined effect at 0.1 µM (45.7 ± 5.7 and 43.0 ± 6.9% inhibition at −50 and −110 mV, respectively) was significantly higher than a simple sum of almost negligible effects of the individual substances and it led to a significant prolongation of APD at both 23 and 37°C. To our knowledge, similar potentiation of the drug-channel interaction has not been described. The observed massive inhibition of I K1 induced by a combined action of the vasodilator sildenafil and environmental contaminant Ba 2+ at a low concentration and resulting in a significant APD prolongation may contribute to the genesis of arrhythmias observed in some patients treated with sildenafil.
No takes yet. Share an insight, caveat, or question.
Macháček et al. (2022) studied this question. Sildenafil and Ba2+ vs. Individual substances (sildenafil alone, Ba2+ alone) and control was evaluated on Inhibition of inward rectifier potassium current (IK1) at -50 mV (p=<0.05). Simultaneous application of 0.1 µM sildenafil and 0.1 µM Ba2+ synergistically inhibited inward rectifier potassium current by 45.7% and significantly prolonged action potential duration.
Synapse has enriched 10 related papers. Consider them for comparative context: